Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 34 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

32%

11 trials in Phase 3/4

Results Transparency

0%

0 of 13 completed trials have results

Key Signals

13 recruiting

Enrollment Performance

Analytics

Phase 2
13(39.4%)
Phase 3
10(30.3%)
Phase 1
9(27.3%)
Phase 4
1(3.0%)
33Total
Phase 2(13)
Phase 3(10)
Phase 1(9)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (34)

Showing 20 of 34 trials
NCT07269769Phase 3Not Yet Recruiting

A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD

Role: lead

NCT07485595Phase 2Not Yet Recruiting

A Study of the Effectiveness and Safety of JS1-1-01 Tablet in Patients With Moderate to Severe Depression

Role: lead

NCT06068478Phase 3Completed

A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis

Role: lead

NCT06068465Phase 3Completed

A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Role: lead

NCT07318818Phase 1Recruiting

A Clinical Trial of P134 Cells in Recurrent Glioblastoma

Role: lead

NCT07389460Phase 3Not Yet Recruiting

Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)

Role: collaborator

NCT07371624Phase 1Recruiting

A Study of the Safety, Tolerability and Preliminary Efficacy of B2065 in Patients With Acute Ischemic Stroke.

Role: lead

NCT06696261Phase 3Recruiting

A Study of Lianxiaxiaopi Granules in the Treatment of Postprandial Distress Syndrome

Role: lead

NCT07265349Phase 1Recruiting

A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure

Role: lead

NCT06259526Phase 2Completed

A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression

Role: lead

NCT06773117Phase 3Not Yet Recruiting

Phase III Trial of Susu Zhike Granules in Children With Cold-cough Syndrome for Acute Cough Treatment

Role: lead

NCT04983043Phase 2Completed

Efficacy and Safety of QiShen YiQi Dripping Pills in Chronic Heart Failure

Role: lead

NCT04944706Phase 2Completed

Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction

Role: lead

NCT06753890Phase 3Not Yet Recruiting

Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)

Role: lead

NCT06000956Phase 3Recruiting

A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo

Role: lead

NCT06697886Phase 3Recruiting

A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold

Role: lead

NCT05656274Phase 1Completed

A Study of the Safety,Tolerability,and Pharmacokinetics of Multiple-Ascending Dose JS1-1-01 in Healty Subjects.

Role: lead

NCT06685978Phase 3Recruiting

Efficacy and Safety of Xiangjurupining Capsule for Hyperplasia of Mammary Glands

Role: lead

NCT06669169Phase 2Not Yet Recruiting

Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure

Role: lead

NCT04492787Phase 2Completed

Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)

Role: lead